Noa Biran, MD, Oncology, Hackensack, NJ, Hackensack Meridian Health Hackensack University Medical Center

NoaBiranMD

Oncology Hackensack, NJ

Hematologic Oncology

Physician

Dr. Biran is on Doximity

As a Doximity member you'll join over a million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Biran's full profile

Already have an account?

Summary

  • Dr. Noa Biran is an oncologist in Hackensack, NJ and is affiliated with Hackensack Meridian Health Hackensack University Medical Center. She received her medical degree from George Washington University School of Medicine and has been in practice 9 years. She specializes in hematologic oncology and is experienced in amyloidosis, hematologic oncology, myelodysplasia, myelofibrosis, and multiple myeloma.

Education & Training

  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineFELLOWSHIP
  • Mount Sinai School of Medicine
    Mount Sinai School of MedicineRESIDENCY
  • George Washington University School of Medicine
    George Washington University School of MedicineMEDICAL_SCHOOL

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2014 - 2021
  • NY State Medical License
    NY State Medical License 2009 - Present
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Response to Therapy and the Effectiveness of Treatment with Selinexor and Dexamethasone in Patients with Penta-Exposed Triple-Class Refractory Myeloma Who Had Plasmacy...
    Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Building a National CML Registry
    Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Engraftment Syndrome in the Setting of Autologous Stem Cell Transplantation for Multiple Myeloma-a Single Institution Review of over 600 Patients
    Noa Biran, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Join now to see all

Lectures

  • Phase I/II Study of Escalating Doses of Thalidomide in Conjunction with Bortezomib and High Dose Melphalan As a Conditioning Regimen for Autologous Stem Cell Transplan... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treat... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Safety and Efficacy Data for Combined Checkpoint Inhibition with Ipilimumab (Ipi) and Nivolumab (Nivo) As Consolidation Following Autologous Stem Cell Transplantation ... 
    2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
  • Join now to see all

Authored Content

  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020
  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020

Press Mentions

  • Dr. Biran on Post-ASCT Consolidation in Multiple Myeloma
    Dr. Biran on Post-ASCT Consolidation in Multiple MyelomaJanuary 31, 2020
  • Hosts State of the Science Summit
    Hosts State of the Science SummitMarch 19, 2018
  • John Theurer Cancer Center Researchers Share 46 Cutting Edge Studies at 2017 ASH Meeting
    John Theurer Cancer Center Researchers Share 46 Cutting Edge Studies at 2017 ASH MeetingDecember 04, 2017
  • Join now to see all

Hospital Affiliations